Trending...
- Heartland Restaurant Group Seeks General Managers to Support Continued Growth
- Power Conference 2023 Prelude - Release Service
- Charlotte Company Buys Unpaid Judgments in Mecklenburg and Iredell County
HORSHAM, Pa.--(BUSINESS WIRE)--Myonex, a leading global clinical trial supply company, announces the launch of the first and only on-demand local drug sourcing in Europe. Built on a successful North American program, CTRx Europe offers significant benefits for trial sponsors, sites, and patients alike.
"With the growth of our CTRx service in North America, clients have been asking us to develop the same solution for them in Europe. Our new CTRx Europe solution is a game-changer for clinical sites in Europe," said James Lovett, Chief Executive Officer at Myonex. "Our solution will offer support for sites to source local drug for local patients, in individual European countries. Sponsors can remove overage and eliminate costs associated with up-front bulk comparator purchases, inventory management, and expired drugs. The program has delivered tremendous results in the United States and Canada, and we are pleased to be able to offer similar flexibility and savings in Europe."
More on The PennZone
Through its partnerships with central dispensing pharmacies in major European markets, Myonex can offer on-demand local sourcing. The CTRx solution provides sponsors with in-country local pricing and access to key oncology and other specialty medications and hospital lines. Sites need less storage space and fewer resources, so they can accommodate more trials. Sponsors can track dispensing via a secure, GDPR-compliant portal, and sites can request orders online.
Myonex's CTRx solution supports traditional, decentralized, and hybrid trials. In processes tailored to meet local regulations, both sponsor investigational medicinal products and commercial drugs, as well as ancillary items, can be delivered directly to the clinical site, central nursing center, a nurse, or even to the patient's home.
"The direct-to-patient offering makes adherence easier," said Samit Bhatt, Senior Director, Clinical Trial Patient Solutions, at Myonex. "And because our local partners serve local markets, logistics costs per patient and site shipment are lower, and sponsors can see significantly improved study start-up time."
More on The PennZone
CTRx Europe is part of an end-to-end suite of clinical trial supply solutions from Myonex that also includes expanded packaging and labeling capabilities; warehousing, storage, and distribution; project management and more. For information, email globalsales@myonex.com.
About Myonex
Myonex is a leading global clinical trial supply company with more than 30 years of experience supporting sponsors that range from Big Pharma to small biotech, as well as CROs, and other service providers. Its four unique services—sourcing, packaging/labeling, ancillaries and patient solutions—work together to create flexibility, improve effectiveness, increase efficiency and eliminate waste. The company problem-solves and tailors solutions to the specific requirements and complexities of each trial, and sponsors and CROs benefit from the simplicity of having a single vendor that can provide an optimized, integrated clinical trial supply strategy that saves time and money. Learn more at www.myonex.com.
Contacts
Maryanne Walsh
+1 267-307-0876
"With the growth of our CTRx service in North America, clients have been asking us to develop the same solution for them in Europe. Our new CTRx Europe solution is a game-changer for clinical sites in Europe," said James Lovett, Chief Executive Officer at Myonex. "Our solution will offer support for sites to source local drug for local patients, in individual European countries. Sponsors can remove overage and eliminate costs associated with up-front bulk comparator purchases, inventory management, and expired drugs. The program has delivered tremendous results in the United States and Canada, and we are pleased to be able to offer similar flexibility and savings in Europe."
More on The PennZone
- Delaware Enhanced Global Dividend and Income Fund announces potential self-tender offer for up to 30% of its shares
- The East TOKYO Festival of Light launches in Tokyo, Presented by Tobu Railway Group
- Magnolias of Chambersburg Cuisineur Brings Decade of Experience to Senior Community
- Yida Gao and Shima Capital Invest in Web3 Gaming Startup Midnight
- Kessel Construction, Inc. Achieves AC478 Accreditation
Through its partnerships with central dispensing pharmacies in major European markets, Myonex can offer on-demand local sourcing. The CTRx solution provides sponsors with in-country local pricing and access to key oncology and other specialty medications and hospital lines. Sites need less storage space and fewer resources, so they can accommodate more trials. Sponsors can track dispensing via a secure, GDPR-compliant portal, and sites can request orders online.
Myonex's CTRx solution supports traditional, decentralized, and hybrid trials. In processes tailored to meet local regulations, both sponsor investigational medicinal products and commercial drugs, as well as ancillary items, can be delivered directly to the clinical site, central nursing center, a nurse, or even to the patient's home.
"The direct-to-patient offering makes adherence easier," said Samit Bhatt, Senior Director, Clinical Trial Patient Solutions, at Myonex. "And because our local partners serve local markets, logistics costs per patient and site shipment are lower, and sponsors can see significantly improved study start-up time."
More on The PennZone
- Pennsylvania: Gov. Wolf: Don't Miss Last Chance to Apply for Property Tax/Rent Rebate Program and Bonus Rebate
- Pennsylvania: Gov. Wolf: $220,000 in New Funding to Assist Local Governments in Seven Counties with Zoning and Comprehensive Plans
- Benjamin Ross Group, LLC Sells Wholesale/Distribution Company, Philadelphia, PA
- Trinseo Announces Quarterly Dividend of $0.32 Per Share
- Play time for edge computing is over—full scale deployments in 2023, predicts IOTech
CTRx Europe is part of an end-to-end suite of clinical trial supply solutions from Myonex that also includes expanded packaging and labeling capabilities; warehousing, storage, and distribution; project management and more. For information, email globalsales@myonex.com.
About Myonex
Myonex is a leading global clinical trial supply company with more than 30 years of experience supporting sponsors that range from Big Pharma to small biotech, as well as CROs, and other service providers. Its four unique services—sourcing, packaging/labeling, ancillaries and patient solutions—work together to create flexibility, improve effectiveness, increase efficiency and eliminate waste. The company problem-solves and tailors solutions to the specific requirements and complexities of each trial, and sponsors and CROs benefit from the simplicity of having a single vendor that can provide an optimized, integrated clinical trial supply strategy that saves time and money. Learn more at www.myonex.com.
Contacts
Maryanne Walsh
+1 267-307-0876
Filed Under: Business
0 Comments
Latest on The PennZone
- Actuated Medical Awarded NIH SBIR for the Miniature Ultrasound Beamforming Array (MUBA)
- MBCEA Midwest Chapter Elects Jeff Wolgamott President
- Pennsylvania Commission for Women Opens Nomination Period for 2023 Female Veterans Day Celebration
- High Quality Veneers Available at Center Valley Dental
- Pennsylvania: Gov. Wolf Highlights $2.5 Million Capital Investment for Philadelphia LGBT Community Center Renovations
- Southampton Dental Practice Offering Affordable Dentures
- The Sound Hotel Seattle Belltown Adds Private Wireless from Comcast Business to its List of Amenities
- National Lacrosse League Announces Playoff Format and Playoff Schedule For 2022-23 Season
- Barcoding, Inc. Joins Zebra Technologies' PartnerConnect Mobile Robotics Specialization
- Advantage Anywhere Launches a Joint Venture and Licensing Partner Program for the Senior Living Industry
- Radian's "Opens Doors Opens Hearts" Campaign Exceeds Fundraising Goal for the MBA Opens Doors Foundation
- Australia's IRAP Assessment Recognizes Boomi To Provide Comprehensive Security Controls
- Sojazzie Home Girl of Delgado Realty & Real African Art Gallery's Home For The Holidays Give Back
- Jason Halbert Exits Apollo Health Products to Expand 3Back Group
- CORRECTING and REPLACING ERIKS North America Announces Appointment of Annette Camuso-Sarsfield as Chief Human Resources Officer
- Pennsylvania: Governor Wolf Announces $9 Million for Substance Use Disorder Crisis Stabilization Services
- Pennsylvania: Gov. Wolf Announces Plan to Expand Broadband Across Commonwealth
- Heartland Restaurant Group Seeks General Managers to Support Continued Growth
- Mereo Capital Partners and Hyperion Capital Partners Acquire Rapidly Growing Manufacturer of Packaging Solutions
- Netberg launches Aurora 810 platform for next-generation networks